These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 11485902

  • 21. Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease.
    Camboni M, Wang CM, Miranda C, Yoon JH, Xu R, Zygmunt D, Kaspar BK, Martin PT.
    Neurobiol Dis; 2014 Feb; 62():31-43. PubMed ID: 24021662
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Virosome-based active immunization targets soluble amyloid species rather than plaques in a transgenic mouse model of Alzheimer's disease.
    Zurbriggen R, Amacker M, Kammer AR, Westerfeld N, Borghgraef P, Van Leuven F, Van der Auwera I, Wera S.
    J Mol Neurosci; 2005 Feb; 27(2):157-66. PubMed ID: 16186626
    [Abstract] [Full Text] [Related]

  • 24. Aβ-HBc virus-like particles immunization without additional adjuvant ameliorates the learning and memory and reduces Aβ deposit in PDAPP mice.
    Jin H, Wang W, Zhao S, Yang W, Qian Y, Jia N, Feng G.
    Vaccine; 2014 Jul 31; 32(35):4450-4456. PubMed ID: 24962758
    [Abstract] [Full Text] [Related]

  • 25. Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage.
    Nikolic WV, Bai Y, Obregon D, Hou H, Mori T, Zeng J, Ehrhart J, Shytle RD, Giunta B, Morgan D, Town T, Tan J.
    Proc Natl Acad Sci U S A; 2007 Feb 13; 104(7):2507-12. PubMed ID: 17264212
    [Abstract] [Full Text] [Related]

  • 26. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL, Biron KE, Ujiie M, Pfeifer CG, Jeffries AR, Jefferies WA.
    FASEB J; 2006 Mar 13; 20(3):426-33. PubMed ID: 16507760
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42).
    Town T, Vendrame M, Patel A, Poetter D, DelleDonne A, Mori T, Smeed R, Crawford F, Klein T, Tan J, Mullan M.
    J Neuroimmunol; 2002 Nov 13; 132(1-2):49-59. PubMed ID: 12417433
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A safer vaccine for Alzheimer's disease?
    Sigurdsson EM, Wisniewski T, Frangione B.
    Neurobiol Aging; 2002 Nov 13; 23(6):1001-8. PubMed ID: 12470795
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease.
    Minami SS, Sidahmed E, Aid S, Shimoji M, Niikura T, Mocchetti I, Rebeck GW, Prendergast JS, Dealwis C, Wetzel R, Bosetti F, Matsuoka Y, Hoe HS, Turner RS.
    J Neuroinflammation; 2010 Sep 28; 7():57. PubMed ID: 20920207
    [Abstract] [Full Text] [Related]

  • 35. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y, Kim HD, Lee MK, Hong IH, Won CK, Bai HW, Lee SS, Lee S, Chung BY, Cho JH.
    PLoS One; 2017 Sep 28; 12(1):e0169509. PubMed ID: 28072821
    [Abstract] [Full Text] [Related]

  • 36. Passive immunization of the Abeta42(43) C-terminal-specific antibody BC05 in a mouse model of Alzheimer's disease.
    Asami-Odaka A, Obayashi-Adachi Y, Matsumoto Y, Takahashi H, Fukumoto H, Horiguchi T, Suzuki N, Shoji M.
    Neurodegener Dis; 2005 Sep 28; 2(1):36-43. PubMed ID: 16909001
    [Abstract] [Full Text] [Related]

  • 37. Conformation-sensitive antibodies against alzheimer amyloid-beta by immunization with a thioredoxin-constrained B-cell epitope peptide.
    Moretto N, Bolchi A, Rivetti C, Imbimbo BP, Villetti G, Pietrini V, Polonelli L, Del Signore S, Smith KM, Ferrante RJ, Ottonello S.
    J Biol Chem; 2007 Apr 13; 282(15):11436-45. PubMed ID: 17267402
    [Abstract] [Full Text] [Related]

  • 38. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
    Browne TC, McQuillan K, McManus RM, O'Reilly JA, Mills KH, Lynch MA.
    J Immunol; 2013 Mar 01; 190(5):2241-51. PubMed ID: 23365075
    [Abstract] [Full Text] [Related]

  • 39. Immunization of Tg-APPswe/PSEN1dE9 mice with Aβ3-10-KLH vaccine prevents synaptic deficits of Alzheimer's disease.
    Meng Y, Ding L, Zhang H, Yin W, Yan Y, Cao Y.
    Behav Brain Res; 2017 Aug 14; 332():64-70. PubMed ID: 28577919
    [Abstract] [Full Text] [Related]

  • 40. Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice.
    Santuccione AC, Merlini M, Shetty A, Tackenberg C, Bali J, Ferretti MT, McAfoose J, Kulic L, Bernreuther C, Welt T, Grimm J, Glatzel M, Rajendran L, Hock C, Nitsch RM.
    Mol Psychiatry; 2013 Mar 14; 18(3):358-68. PubMed ID: 22688190
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.